Neonatal Hypoglycemia: A Systematic Review of International and Local Clinical Guidelines with Clinical Implications

Camelia Rusu1,2, Melinda Matyas3, Boris W Kramer4

  • 1Department of Medical Disciplines, University of Oradea, 410073 Oradea, Romania.

Insights

Neonatal hypoglycemia management guidelines vary internationally. This review compares key guidelines, finding consensus on core principles but highlighting differences in screening and treatment thresholds for newborn blood glucose levels.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Clinical Guidelines

Background:

  • Neonatal hypoglycemia is a frequent metabolic issue in newborns.
  • Existing international and local guidelines present inconsistencies in screening, thresholds, and management.

Purpose of the Study:

  • To systematically review and compare international and local clinical guidelines for neonatal hypoglycemia management.
  • To identify variations and commonalities in risk assessment, screening, and treatment protocols.

Main Methods:

  • Systematic comparative review of major international and regional guidelines.
  • Analysis of recommendations on risk factors, screening protocols, blood glucose thresholds, and NICU admission criteria.

Main Results:

  • All reviewed guidelines advocate for targeted screening of at-risk neonates and prompt treatment of symptomatic hypoglycemia.
  • Significant variation exists in the recommended timing for initial blood glucose measurement, screening frequency, and minimum glucose thresholds for intervention.
  • Current guidelines support oral dextrose gel (40%) as a primary treatment for specific cases.

Conclusions:

  • Despite numerical discrepancies, major guidelines align on fundamental principles for managing neonatal hypoglycemia.
  • Further research is needed to standardize intervention thresholds and optimize blood glucose measurement strategies.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...